📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Inspire Medical Systems Inc

Common Name
Inspire Medical Systems
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
1,246
Ticker
INSP
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship pr...

Inspire Medical Systems's GHG Emissions Data Preview

In 2023, Inspire Medical Systems completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Inspire Medical Systems has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=INSP&reporting_period=2024"

Verified Sources Behind Inspire Medical Systems’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Inspire Medical Systems’s data sources below and access millions more through our Disclosure Search.

a. Inspire Medical Systems's Sustainability Report 2024
a. Inspire Medical Systems's Sustainability Report 2024

Insights into Inspire Medical Systems's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions ofInspire Medical Systems amounted to452.37metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Inspire Medical Systems's Scope 1 Emissions Over Time

2023015304560tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Inspire Medical Systems's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Inspire Medical Systems were 50.63 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

What are Inspire Medical Systems's Scope 2 emissions?

In 2023, Inspire Medical Systems reported Scope 2 greenhouse gas (GHG) emissions of 401.74 tCOâ‚‚e without specifying the calculation method.a

What methodology does Inspire Medical Systems use for Scope 2 reporting?

In 2023, Inspire Medical Systems reported its Scope 2 emissions using an unspecified methodology.a

Inspire Medical Systems's Scope 2 Emissions Over Time

20230150300450600tCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Inspire Medical Systems's Value Chain Emissions

In 2023, Inspire Medical Systems reported 55,766.65 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a

The 2023 disclosure of Inspire Medical Systems includes a breakdown across 10of the 15 Scope 3 categories defined by the GHG Protocol,up from 0 in , reflecting improved emissions accounting practices and greater transparency across the company's value chaina

Inspire Medical Systems's Scope 3 Emissions Over Time

2023015 k30 k45 k60 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Inspire Medical Systems's Scope 3 emissions?

In 2023, Inspire Medical Systems reported total Scope 3 emissions of 55,766.65 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

Approximately 98.1%of these emissions originated from upstream activities such as purchased goods and capital goods, while 1.9%came from downstream activities like product use, distribution, and end-of-life treatment.a

What categories of Scope 3 emissions does Inspire Medical Systems disclose?

In 2023, Inspire Medical Systems reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.a

This reflects a high level of granularity and transparency in the company's emissions reporting.

What are the main sources of Inspire Medical Systems's Scope 3 emissions?

In 2023, the largest contributors to Inspire Medical Systems's Scope 3 emissions were:a

  • Purchased Goods and Services (Cat. 1): 41,471.85 tCOâ‚‚e(74.37%)
  • Business Travel (Cat. 6): 6,602.15 tCOâ‚‚e(11.84%)
  • Capital Goods (Cat. 2): 3,981.71 tCOâ‚‚e(7.14%)

Inspire Medical Systems's Scope 3 Emissions by Categories

Capital Goods(Cat. 2)(7.1%)Business Travel(Cat. 6)(11.8%)Purchased Goods andServices (Cat. 1)(74.4%)

Insights into Inspire Medical Systems’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Inspire Medical Systems reported Scope 1 greenhouse gas (GHG) emissions of 50.63 tCOâ‚‚e and total revenues of USD 625 millions. This translates into an emissions intensity of 0.08 tCOâ‚‚e per millions USD.a

Inspire Medical Systems's Scope 1 Emissions Intensity Compared to Peers

205005,000100,0002,000,000Scope 1 Emissions (tCO2e)1005005,00020,000100,000Revenues (Millions of USD)IInteger HoldingsYear: 2023Scope 1: 7,066 tCO2eRevenue: $M 1,597Scope 1 Intensity: 4.43 tCO2e/$MEnovisYear: 2024Scope 1: 2,321 tCO2eRevenue: $M 2,108Scope 1 Intensity: 1.10 tCO2e/$MAzentaYear: 2024Scope 1: 4,147 tCO2eRevenue: $M 656Scope 1 Intensity: 6.32 tCO2e/$MAbbott LaboratoriesYear: 2024Scope 1: 502,000 tCO2eRevenue: $M 41,950Scope 1 Intensity: 11.97 tCO2e/$MInsuletYear: 2024Scope 1: 1,383 tCO2eRevenue: $M 2,072Scope 1 Intensity: 0.67 tCO2e/$MBio Rad LaboratoriesYear: 2023Scope 1: 10,563 tCO2eRevenue: $M 2,671Scope 1 Intensity: 3.95 tCO2e/$MR1 RCM HoldcoYear: 2023Scope 1: 676 tCO2eRevenue: $M 2,254Scope 1 Intensity: 0.30 tCO2e/$MEdwards LifesciencesYear: 2024Scope 1: 15,682 tCO2eRevenue: $M 5,439Scope 1 Intensity: 2.88 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MGlaukosYear: 2024Scope 1: 523 tCO2eRevenue: $M 383Scope 1 Intensity: 1.36 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MMerit Medical SystemsYear: 2024Scope 1: 2,875 tCO2eRevenue: $M 1,357Scope 1 Intensity: 2.12 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MStrykerYear: 2023Scope 1: 54,854 tCO2eRevenue: $M 20,498Scope 1 Intensity: 2.68 tCO2e/$MZimmer Biomet HoldingsYear: 2024Scope 1: 10,191 tCO2eRevenue: $M 7,679Scope 1 Intensity: 1.33 tCO2e/$MAvanos MedicalYear: 2023Scope 1: 1,787 tCO2eRevenue: $M 673Scope 1 Intensity: 2.65 tCO2e/$MIIIntegra Lifesciences HoldingsYear: 2024Scope 1: 14,555 tCO2eRevenue: $M 1,611Scope 1 Intensity: 9.04 tCO2e/$MDexcomYear: 2024Scope 1: 8,328 tCO2eRevenue: $M 4,033Scope 1 Intensity: 2.07 tCO2e/$MBoston ScientificYear: 2024Scope 1: 87,567 tCO2eRevenue: $M 16,747Scope 1 Intensity: 5.23 tCO2e/$MQuidelOrthoYear: 2023Scope 1: 22,544 tCO2eRevenue: $M 2,998Scope 1 Intensity: 7.52 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MInspire Medical SystemsYear: 2023Scope 1: 51 tCO2eRevenue: $M 625Scope 1 Intensity: 0.08 tCO2e/$M

How does Inspire Medical Systems's GHG emissions intensity compare to its peers?

In 2023, Inspire Medical Systems reported a Scope 1 emissions intensity of 0.08 tCOâ‚‚e per millions USD. Compared to the peer group median of 2.65, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a

Where does Inspire Medical Systems rank on GHG emissions intensity within its industry?

In 2023, Inspire Medical Systems ranked 1 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Inspire Medical Systems among the top performers, with one of the lowest emissions intensities relative to peers.a

Insights into Inspire Medical Systems's Total Carbon Footprint

In 2023, Inspire Medical Systems reported a total carbon footprint of 56,219.02 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions.a

The largest contributor to Inspire Medical Systems's total carbon footprint was Scope 3 emissions, accounting for 99.2% of the company's total carbon footprint, followed by Scope 2 emissions at 0.71%.a

Want Full Access to Inspire Medical Systems's GHG Emissions Dataset?
Sign Up